EP1233671A4 - Compositions et methodes d'administration de medicaments au moyen de molecules de liaison amphiphiles - Google Patents

Compositions et methodes d'administration de medicaments au moyen de molecules de liaison amphiphiles

Info

Publication number
EP1233671A4
EP1233671A4 EP00982310A EP00982310A EP1233671A4 EP 1233671 A4 EP1233671 A4 EP 1233671A4 EP 00982310 A EP00982310 A EP 00982310A EP 00982310 A EP00982310 A EP 00982310A EP 1233671 A4 EP1233671 A4 EP 1233671A4
Authority
EP
European Patent Office
Prior art keywords
compositions
methods
drug delivery
binding molecules
amphiphile
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00982310A
Other languages
German (de)
English (en)
Other versions
EP1233671A1 (fr
Inventor
Jon A Wolff
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Arrowhead Madison Inc
Original Assignee
Mirus Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mirus Corp filed Critical Mirus Corp
Publication of EP1233671A1 publication Critical patent/EP1233671A1/fr
Publication of EP1233671A4 publication Critical patent/EP1233671A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0008—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition
    • A61K48/0025—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition wherein the non-active part clearly interacts with the delivered nucleic acid
    • A61K48/0041—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition wherein the non-active part clearly interacts with the delivered nucleic acid the non-active part being polymeric
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/88—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP00982310A 1999-11-29 2000-11-29 Compositions et methodes d'administration de medicaments au moyen de molecules de liaison amphiphiles Withdrawn EP1233671A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16783699P 1999-11-29 1999-11-29
US167836P 1999-11-29
PCT/US2000/032612 WO2001037665A1 (fr) 1999-11-29 2000-11-29 Compositions et methodes d'administration de medicaments au moyen de molecules de liaison amphiphiles

Publications (2)

Publication Number Publication Date
EP1233671A1 EP1233671A1 (fr) 2002-08-28
EP1233671A4 true EP1233671A4 (fr) 2005-11-02

Family

ID=22609038

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00982310A Withdrawn EP1233671A4 (fr) 1999-11-29 2000-11-29 Compositions et methodes d'administration de medicaments au moyen de molecules de liaison amphiphiles

Country Status (2)

Country Link
EP (1) EP1233671A4 (fr)
WO (1) WO2001037665A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7091192B1 (en) 1998-07-01 2006-08-15 California Institute Of Technology Linear cyclodextrin copolymers
US6509323B1 (en) 1998-07-01 2003-01-21 California Institute Of Technology Linear cyclodextrin copolymers
US7375096B1 (en) 1998-12-04 2008-05-20 California Institute Of Technology Method of preparing a supramolecular complex containing a therapeutic agent and a multi-dimensional polymer network
TWI321054B (en) 2000-12-19 2010-03-01 California Inst Of Techn Compositions containing inclusion complexes
JP2005527639A (ja) * 2001-11-02 2005-09-15 インサート セラピューティクス インコーポレイテッド Ｒｎａ干渉の治療的利用のための方法及び組成物
EP1507874A4 (fr) * 2002-05-28 2006-06-28 Mirus Bio Corp Compositions et procedes d'inhibition de l'expression genetique au moyen de polynucleotides
FR2842106B1 (fr) * 2002-07-11 2006-07-14 Centre Nat Rech Scient Dispersions aqueuses de particules nanometriques ou micrometriques pour l'encapsulation de composes chimiques
PT1534340E (pt) 2002-09-06 2012-03-13 Cerulean Pharma Inc Polímeros à base de ciclodextrina para a administração de medicamentos ligados por ligação covalente
RU2005114007A (ru) 2002-10-09 2005-10-10 Инсерт Терапьютикс, Инк. (Us) Материалы на основе циклодекстринов, их композиции и применение
JP2010516625A (ja) 2007-01-24 2010-05-20 インサート セラピューティクス， インコーポレイテッド 制御された薬物送達のためのテザー基を有するポリマー−薬物コンジュゲート
EP2438908A1 (fr) 2010-10-11 2012-04-11 Vectum Pharma, S.L. Compositions d'ancrage pour applications topiques
WO2014055493A1 (fr) 2012-10-02 2014-04-10 Cerulean Pharma Inc. Procédés et systèmes s'appliquant à la précipitation de polymères et à la génération de particules

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000001418A1 (fr) * 1998-07-02 2000-01-13 Genzyme Corporation Expression transgenique dans des cellules polarisees
WO2001015755A2 (fr) * 1999-09-01 2001-03-08 Genecure Pte Ltd Procedes et compositions d'administration d'agents pharmaceutiques

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5283185A (en) * 1991-08-28 1994-02-01 University Of Tennessee Research Corporation Method for delivering nucleic acids into cells
US5650096A (en) * 1994-12-09 1997-07-22 Genzyme Corporation Cationic amphiphiles for intracellular delivery of therapeutic molecules
US5965434A (en) * 1994-12-29 1999-10-12 Wolff; Jon A. Amphipathic PH sensitive compounds and delivery systems for delivering biologically active compounds
US5942634A (en) * 1997-05-09 1999-08-24 Genzyme Corporation Cationic amphiphiles for cell transfections

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000001418A1 (fr) * 1998-07-02 2000-01-13 Genzyme Corporation Expression transgenique dans des cellules polarisees
WO2001015755A2 (fr) * 1999-09-01 2001-03-08 Genecure Pte Ltd Procedes et compositions d'administration d'agents pharmaceutiques

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
CROYLE MA ET AL: "Beta cyclodextrins enhance gene delivery to the intestine", PROCEEDINGS OF THE INTERNATIONAL SYMPOSIUM ON CONTROLLED RELEASE BIOACTIVE MATERIALS, vol. 24, 1997, pages 675 - 676, XP002122911, ISSN: 1022-0178 *
FREEMAN D J ET AL: "THE INFLUENCE OF SODIUM GLYCOCHOLATE AND OTHER ADDITIVES ON THE IN VIVO TRANSFECTION OF PLASMID DNA IN THE LUNGS", PHARMACOLOGICAL RESEARCH, ACADEMIC PRESS, LONDON, GB, vol. 13, no. 2, 1 February 1996 (1996-02-01), pages 202 - 209, XP000646438, ISSN: 1043-6618 *
HABUS I ET AL: "SYNTHESIS, HYBRIDIZATION PROPERTIES, NUCLEASE STABILITY, AND ADAMANTANE CONJUGATES. CELLULAR UPTAKE OF THE OLIGONUCLEOTIDE-AMINO- CYCLODEXTRINS AND", BIOCONJUGATE CHEMISTRY, AMERICAN CHEMICAL SOCIETY, WASHINGTON, US, vol. 6, no. 4, 1 July 1995 (1995-07-01), pages 327 - 331, XP000517222, ISSN: 1043-1802 *
See also references of WO0137665A1 *

Also Published As

Publication number Publication date
WO2001037665A1 (fr) 2001-05-31
EP1233671A1 (fr) 2002-08-28

Similar Documents

Publication Publication Date Title
TWI367096B (en) Vitamin-receptor binding drug delivery conjugates and pharmaceutical compositions
AU3692001A (en) Compositions and methods for enhancing drug delivery across biological membranesand tissues
AU2001235009A1 (en) Drug delivery apparatus
IL138990A0 (en) Matrices for drug delivery and methods for making and using the same
HUP0203588A3 (en) Analgesic pharmaceutical compositions and their use
EP1367995A4 (fr) Compositions et methodes servant a renforcer la diffusion de medicaments a travers et dans des tissus epitheliaux
HK1049438B (zh) 榫型藥物輸送裝置
IL144325A0 (en) Compositions and methods for mucosal delivery
AU2001232049A1 (en) Improvements in and relating to controlling drug delivery apparatus
PL351387A1 (en) Pharmaceutical composition
IL149186A0 (en) Pharmaceutical compositions providing enhanced drug concentrations
PT1239831E (pt) Composições farmacêuticas melhoradas para fármacos fracamente solúveis
AU5326100A (en) Pharmaceutical compositions and methods for use
GB2355252B (en) Improvements in drug delivery devices
IL151910A0 (en) Compositions for drug delivery
HUP0302130A3 (en) Combination pharmaceutical compositions and process for their preparation
EP1233671A4 (fr) Compositions et methodes d'administration de medicaments au moyen de molecules de liaison amphiphiles
EP1165597A4 (fr) Molecules bifonctionnelles pour administration d'agents therapeutiques
IL137559A0 (en) Transdermal drug delivery system
HUP0200468A3 (en) Resorcinol derivatives and pharmaceutical compositions containing them
IL153487A0 (en) Pharmaceutical compositions and methods for use
EP1173192A4 (fr) Procedes et compositions pour administration ciblee de medicaments
AU3926000A (en) Methods and compositions for drug delivery
IL153897A0 (en) Pharmaceutical compositions and methods for use
AU2002308649A1 (en) Compositions and methods for enhancing drug delivery

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20020612

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

A4 Supplementary search report drawn up and despatched

Effective date: 20050919

RIC1 Information provided on ipc code assigned before grant

Ipc: 7A 61K 48/00 A

Ipc: 7C 12N 15/88 B

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20051202